Dr Reddys Laboratories (RDY) Change in Inventory (2012 - 2026)
Dr Reddys Laboratories (RDY) recorded quarterly Change in Inventory of $837.2 million in Q1 2026, down 3.69% quarter-over-quarter from $869.3 million in Q3 2025, and up 1.98% on a YoY basis from $820.9 million in Q1 2025.
Dr Reddys Laboratories (RDY) Change in Inventory (2012 - 2026) Analysis & Trends
Dr Reddys Laboratories' Change in Inventory history runs 15 years deep, the most recent figure standing at $837.2 million for Q1 2026.
- In Q1 2026, Change in Inventory rose 1.98% year-over-year to $837.2 million; the TTM figure through Mar 2026 stood at $837.2 million (up 1.98% YoY), while the FY2026 annual figure was -$92.0 million, up 38.26% from the prior year.
- Change in Inventory was $837.2 million for Q1 2026 at Dr Reddys Laboratories, down from $869.3 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $869.3 million in Q3 2025 to a low of -$75.8 million in Q2 2024.
- Historically, Change in Inventory has averaged $491.5 million across 5 years, with a median of $615.1 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Change in Inventory sank 113.68% in 2024, then soared 1553.81% in 2025.
- A 5-year view of Change in Inventory shows it stood at $615.1 million in 2022, then declined by 28.93% to $437.1 million in 2023, then plunged by 113.68% to -$59.8 million in 2024, then jumped by 1553.81% to $869.3 million in 2025, then dropped by 3.69% to $837.2 million in 2026.
- The last three Change in Inventory figures came in at $837.2 million (Q1 2026), $869.3 million (Q3 2025), and -$71.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -93.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 114.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 40.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -4.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 20.30 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -2.11 Mn |
| 10 | Dr Reddys Laboratories | 122.03 Mn | -51.98 Mn | 368.55 Mn | 837.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 837.18 Mn |
| Mar 31, 2026 | 837.18 Mn |
| Sep 30, 2025 | 869.27 Mn |
| Sep 30, 2025 | 869.27 Mn |
| Jun 30, 2025 | -71.86 Mn |
| Jun 30, 2025 | -71.86 Mn |
| Mar 31, 2025 | 820.89 Mn |
| Mar 31, 2025 | 820.89 Mn |
| Sep 30, 2024 | -59.79 Mn |
| Sep 30, 2024 | -59.79 Mn |
| Jun 30, 2024 | -75.80 Mn |
| Jun 30, 2024 | -75.80 Mn |
| Mar 31, 2024 | 765.26 Mn |
| Mar 31, 2024 | 765.26 Mn |
| Sep 30, 2023 | 437.14 Mn |
| Sep 30, 2023 | 437.14 Mn |
| Mar 31, 2023 | 592.06 Mn |
| Mar 31, 2023 | 592.06 Mn |
| Sep 30, 2022 | 615.12 Mn |
| Sep 30, 2022 | 615.12 Mn |